Appointment of MD & CEO and Annual Staff Review Process
Filed with ASX · · 5 pages · English
Earlier from AnteoTech
- Queensland Government Grant Funding Update
- $2.59 million R&D Tax Incentive received
- Agreement for combined Anteo X product in the USA
- Key Technical Milestone Achieved for Ultranode
- AnteoBind Order Received and Life Sciences Update
Later from AnteoTech
- FY2025 Full Year Appendix 4E and Annual Report
- Full Year Results and Business Update Presentation
- Joint Development and Sales Agreement Executed
- Ultranode X achieves more than 1,000 Cycles at 80% Capacity
- Trading Halt
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech